While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver

Source: [CNBC](https://www.cnbc.com/2026/06/19/zealand-pharma-stock-weight-loss-drugmaker-novo-lilly.html)

Sponsored